Clinical Trial Update: Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer

View source ↗

Summary

The clinical trial NCT00934401 evaluating positron emission mammography using fluorothymidine (FLT) to assess chemotherapy response in breast cancer has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fluorothymidine (FLT) (fluorothymidine)

Snippet

Sponsor: University of Iowa | Conditions: Breast Neoplasms | Status: WITHDRAWN